Wearable activity trackers found that PE patients were more active if they underwent mechanical thrombectomy than if they were just put on anticoagulation therapy alone.

IRVINE, CA, UNITED STATES, October 5, 2026 /EINPresswire.com/ -- Innova Vascular, Inc., a medical technology company ...

Please provide your email address to receive an email when new articles are posted on . “SPIRARE opens the door for a new generation of large-bore interventional technology, designed for increased ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the ...

Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The 123-patient SPIRARE II trial (NCT06576427) evaluated ...

Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to ...

A pulmonary embolism occurs when one or more blood clots move from somewhere in your body to the lungs. The clot becomes lodged in a pulmonary (lung) artery and blocks the blood flow. A pulmonary ...

Wearable-derived data provide new insights into how clinical outcomes for patients treated with CAVT and anticoagulation, and ...

A surgical procedure that was virtually abandoned in the 1950s because of its high mortality rates in trying to save patients with acute pulmonary embolism may actually prevent more deaths in severely ...

CONSIDERABLE progress has been made in recent years in the understanding of thromboembolic disease and also in the ability to diagnose acute pulmonary embolism. Radiologists have learned to interpret ...